DE69721747D1 - Methode zur behandlung oder verhütung von interstitieller blasenentzundung - Google Patents

Methode zur behandlung oder verhütung von interstitieller blasenentzundung

Info

Publication number
DE69721747D1
DE69721747D1 DE69721747T DE69721747T DE69721747D1 DE 69721747 D1 DE69721747 D1 DE 69721747D1 DE 69721747 T DE69721747 T DE 69721747T DE 69721747 T DE69721747 T DE 69721747T DE 69721747 D1 DE69721747 D1 DE 69721747D1
Authority
DE
Germany
Prior art keywords
treating
bladder inflammation
preventing interstitial
interstitial bladder
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69721747T
Other languages
English (en)
Other versions
DE69721747T2 (de
Inventor
Smriti Iyengar
A Muhlhauser
B Thor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69721747D1 publication Critical patent/DE69721747D1/de
Publication of DE69721747T2 publication Critical patent/DE69721747T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Threshing Machine Elements (AREA)
  • Processing Of Meat And Fish (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nozzles (AREA)
  • Heat Treatment Of Articles (AREA)
  • Pistons, Piston Rings, And Cylinders (AREA)
  • Transplanting Machines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
DE69721747T 1996-03-11 1997-03-07 Methode zur behandlung oder verhütung von interstitieller blasenentzundung Expired - Lifetime DE69721747T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1315796P 1996-03-11 1996-03-11
US13157P 1996-03-11
PCT/US1997/003410 WO1997033880A1 (en) 1996-03-11 1997-03-07 Methods of treating or preventing interstitial cystitis

Publications (2)

Publication Number Publication Date
DE69721747D1 true DE69721747D1 (de) 2003-06-12
DE69721747T2 DE69721747T2 (de) 2004-04-01

Family

ID=21758595

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69721747T Expired - Lifetime DE69721747T2 (de) 1996-03-11 1997-03-07 Methode zur behandlung oder verhütung von interstitieller blasenentzundung

Country Status (23)

Country Link
EP (1) EP0888330B1 (de)
JP (1) JP2000506863A (de)
KR (1) KR19990087671A (de)
CN (1) CN1217721A (de)
AT (1) ATE239467T1 (de)
AU (1) AU730448B2 (de)
BR (1) BR9708027A (de)
CA (1) CA2250288A1 (de)
CZ (1) CZ287798A3 (de)
DE (1) DE69721747T2 (de)
DK (1) DK0888330T3 (de)
EA (1) EA001325B1 (de)
ES (1) ES2197993T3 (de)
HU (1) HUP9902884A3 (de)
IL (1) IL126159A (de)
NO (1) NO984160D0 (de)
NZ (1) NZ331811A (de)
PL (1) PL328959A1 (de)
PT (1) PT888330E (de)
RO (1) RO117296B1 (de)
UA (1) UA62926C2 (de)
WO (1) WO1997033880A1 (de)
YU (1) YU39598A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU746887B2 (en) 1998-09-15 2002-05-02 Eli Lilly And Company Treatment of persistent pain
EP1383495A1 (de) * 2001-03-29 2004-01-28 Eli Lilly And Company Duloxetine zur verminderung von hitzewallungen
PL223471B1 (pl) * 2002-03-15 2016-10-31 Cypress Bioscience Inc Kompozycja farmaceutyczna zawierająca milnacypran do stosowania w leczeniu zespołu nadwrażliwości jelita grubego
DE10247689A1 (de) * 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
WO2007034503A2 (en) * 2005-06-20 2007-03-29 Cadila Healthcare Limited Controlled release dosage formulation of duloxetine
EP2018860A1 (de) * 2007-07-16 2009-01-28 LEK Pharmaceuticals D.D. Duloxetinzusammensetzung
EP1938840A1 (de) * 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetinzusammensetzung
EP2099492B1 (de) * 2006-12-27 2013-06-05 LEK Pharmaceuticals d.d. Duloxetin-zusammensetzung
WO2009066181A2 (en) * 2007-07-09 2009-05-28 Combino Pharm, S.L. Oral delayed-release duloxentine hydrochloride pellets
RU2719929C1 (ru) * 2018-12-17 2020-04-23 Юрий Анатольевич Игнашов Способ выбора лечения женщин с синдромом болезненного мочевого пузыря

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US574474A (en) * 1897-01-05 Course-indicating apparatus
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence

Also Published As

Publication number Publication date
EA001325B1 (ru) 2001-02-26
UA62926C2 (en) 2004-01-15
WO1997033880A1 (en) 1997-09-18
CN1217721A (zh) 1999-05-26
IL126159A (en) 2003-01-12
YU39598A (sh) 1999-09-27
JP2000506863A (ja) 2000-06-06
NZ331811A (en) 2001-04-27
IL126159A0 (en) 1999-05-09
DK0888330T3 (da) 2003-09-01
EP0888330A4 (de) 1999-04-07
EA199800816A1 (ru) 1999-02-25
EP0888330A1 (de) 1999-01-07
DE69721747T2 (de) 2004-04-01
HUP9902884A2 (en) 2000-07-28
RO117296B1 (ro) 2002-01-30
EP0888330B1 (de) 2003-05-07
NO984160L (no) 1998-09-10
BR9708027A (pt) 1999-08-03
AU2196297A (en) 1997-10-01
NO984160D0 (no) 1998-09-10
AU730448B2 (en) 2001-03-08
PT888330E (pt) 2003-09-30
KR19990087671A (ko) 1999-12-27
CA2250288A1 (en) 1997-09-18
ATE239467T1 (de) 2003-05-15
ES2197993T3 (es) 2004-01-16
HUP9902884A3 (en) 2000-12-28
PL328959A1 (en) 1999-03-01
CZ287798A3 (cs) 1999-05-12

Similar Documents

Publication Publication Date Title
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
ATE411016T1 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
ATE207356T1 (de) Verwendung von tiagabin zur behandlung von schlafstörungen
ATE411018T1 (de) Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
DE69721747D1 (de) Methode zur behandlung oder verhütung von interstitieller blasenentzundung
DE60212613D1 (de) Doxycyclin zur behandlung von akne
DE69027220D1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE69924979D1 (de) Behandlung von chronischen schmerzen
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
DE69919578D1 (de) VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
BR9708037A (pt) Método para o tratamento de abuso de substância
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
EA199800818A1 (ru) Способ лечения бессонницы

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN